Please login to the form below

Not currently logged in
Email:
Password:

AMD

This page shows the latest AMD news and features for those working in and with pharma, biotech and healthcare.

Joerg Moeller to head Bayer R&D after operational shake-up

Joerg Moeller to head Bayer R&D after operational shake-up

The company has suffered a few R&D disappointments of late, however, including the failures of a Regeneron-partnered combination therapy for age-related macular degeneration (AMD) and a drug-device

Latest news

More from news
Approximately 23 fully matching, plus 77 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    In the EU, where there’s a high prevalence of AMD, Bayer has enjoyed great success with Eylea - growing revenues by 18% in 2017, ”says Alice Stevens, analyst, cardiovascular and metabolic ... The company plans to launch the highly anticipated

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    to essential treatment, expanding and improving care for people living with a leading cause of vision loss – age-related macular degeneration (AMD).

  • Deal Watch November 2015 Deal Watch November 2015

    The acquisition brings an ophthalmology focus with products for Stargardt's macular degeneration, dry AMD, and myopic macular degeneration. ... 380. Ocata Therapeutics. Astellas Pharma| Laurel. Acquisition - company. Regenerative medicine pipeline focus

  • Pharma deals during May 2014 Pharma deals during May 2014

    Coincidentally two weeks earlier, there was another deal for a product for treating AMD. ... Regeneron also has a time limited first right of negotiation to Avalanche's VEGF agent in phase IIa for AMD.

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    22. Tracon Pharmaceuticals/ Santen Pharmaceutical Co. Licence. Tracon's anti‐ endoglin antibodies, including TRC105 for wet AMD (p2).

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics